Hood River Capital Management’s Cymabay Therapeutics CBAY Stock Holding History

Hood River Capital Management’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-519,249	Closed	-$12.3M	–	157
2023 Q4	$12.3M	Buy	519,249 +6,838	+1%	+$122K	0.34%	81
2023 Q3	$7.64M	Buy	+512,411	New	+$6.79M	0.25%	88

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Hood River Capital Management's CBAY Position: Q1 2024 in Review

Hood River Capital Management sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 519,249 shares — an estimated $12.3M sold.

Hood River Capital Management first reported a position in CBAY in Q3 2023 and held it in 2 quarters. The position peaked at $12.3M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Hood River Capital Management reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Hood River Capital Management sold 519,249 Cymabay Therapeutics shares in Q1 2024, an estimated $12.3M.
Hood River Capital Management first reported a position in Cymabay Therapeutics in Q3 2023 and held it in 2 quarters.
Hood River Capital Management's Cymabay Therapeutics position peaked at $12.3M in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Hood River Capital Management's 13F filing for Q1 2024, filed 15 May 2024.